Total Visits

Views
Phase 1/2 study of valproic acid and short-course radiotherapy plus capecitabine as preoperative treatment in low-moderate risk rectal cancer-V-shoRT-R3 (Valproic acid--short Radiotherapy--rectum 3rd trial).72

Total Visits Per Month

January 2021February 2021March 2021April 2021May 2021June 2021July 2021
Phase 1/2 study of valproic acid and short-course radiotherapy plus capecitabine as preoperative treatment in low-moderate risk rectal cancer-V-shoRT-R3 (Valproic acid--short Radiotherapy--rectum 3rd trial).03110000

File Downloads

Views
Phase 1/2 study of valproic acid and short-course radiotherapy plus capecitabine as preoperative treatment in low-moderate risk rectal cancer-V-shoRT-R3 (Valproic acid--short Radiotherapy--rectum 3rd trial).pdf86

Top country views

Views
United States56
United Kingdom8
Germany5
Ireland1
India1
Singapore1

Top cities views

Views
Ashburn31
Fairfield9
Oakland4
Changi1
Chelsea1
Dublin1
Hyderabad1
Santa Clara1
Schwalmtal1